Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Lacey Pflibsen, Katherine A. Stang, Michelle D. Sconce, Vanessa B. Wilson, Rebecca L. Hood, Charles K. Meshul, Suzanne H. Mitchell
Dive into the research topics of 'Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease'. Together they form a unique fingerprint.